Technology ID
TAB-4647
Dengue Virus Type 2 Isolates for Development of Diagnostics, Antivirals, and Vaccinations
E-Numbers
E-092-2017-0
Lead Inventor
Munoz-Jordan, Jorge
Lead IC
CDC
Co-Inventors
Schriefer, Martin
ICs
CDC
Applications
Vaccines
Research Materials
Therapeutic Areas
Infectious Disease
Development Stages
Pre-Clinical (in vitro)
This technology includes isolates of the Dengue Virus (type 2) which can be used to develop diagnostic tests, antivirals and vaccinations. These isolates are from Puerto Rico DENV-2 and have complete whole genome sequencing completed. Additionally, these isolates represent current stains of Dengue Virus which are circulating in the Caribbean.
Commercial Applications
Isolates can be used to development diagnostic tests, vaccinations, and antiviral therapies for Dengue Virus.
Competitive Advantages
Representative of current strains circulating among the population.
Licensing Contact: